ID   HLCZ01
AC   CVCL_1J92
DR   Wikidata; Q54889846
RX   Patent=US9989520;
RX   PubMed=24616513;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201309.
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
RX   Patent=US9989520;
RA   Zhu H.-Z., Zuo C.-H., Wang X.-H., Yang D.-R., Liu N.-L.;
RT   "Human hepatoma cell line HLCZ01 and uses thereof.";
RL   Patent number US9989520, 05-Jun-2018.
//
RX   PubMed=24616513; DOI=10.1073/pnas.1320071111;
RA   Yang D.-R., Zuo C.-H., Wang X.-H., Meng X.-H., Xue B.-B., Liu N.-L.,
RA   Yu R., Qin Y.-W., Gao Y.-M., Wang Q.-P., Hu J., Wang L., Zhou Z.-B.,
RA   Liu B., Tan D.-M., Guan Y., Zhu H.-Z.;
RT   "Complete replication of hepatitis B virus and hepatitis C virus in a
RT   newly developed hepatoma cell line.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:E1264-E1273(2014).
//